About
HeartPoint Global inc. is a medical device technology company dedicated to improving lives globally by providing disruptive, safer, cost-effective, accessible, and minimally invasive treatments for numerous cardiovascular indications that annually affect tens of millions of people worldwide. HeartPoint Global's patented device and system, the HeartPoint Global Interventional System (HPGIS), is a first of its kind system of stents that allows for the adjustment of blood flow, at any time during or after initial insertion, in the main pulmonary artery and/or its branches to restore the structure of the heart and function of the heart-lung system, addressing numerous cardiovascular diseases. Initially focusing on left heart issues and structural pulmonary hypertension (for which there is currently no effective treatment) The HPGIS is an investigational device, imminently to be evaluated in clinical trials in Europe. Heartpoint Global Israel Ltd is the company local R&D subsidiary.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of HeartPoint Global's medical device technology?
- HeartPoint Global focuses on developing disruptive, safer, cost-effective, accessible, and minimally invasive treatments for various cardiovascular indications, specifically using its patented HeartPoint Global Interventional System (HPGIS).
- What is the function of HeartPoint Global's Interventional System (HPGIS)?
- The HPGIS is a system of stents designed to allow for the adjustment of blood flow in the main pulmonary artery and/or its branches, either during or after initial insertion, to restore heart structure and heart-lung system function.
- What specific medical conditions is the HPGIS initially targeting?
- The HPGIS is initially focusing on left heart issues and structural pulmonary hypertension, a condition for which there is currently no effective treatment.
- What is the current status of the HPGIS device regarding clinical evaluation?
- The HPGIS is an investigational device that is imminently to be evaluated in clinical trials in Europe.
- When was HeartPoint Global founded?
- HeartPoint Global was founded in 2018.
- What is the status of HeartPoint Global's operations in Israel?
- HeartPoint Global's Israeli R&D subsidiary, Heartpoint Global Israel Ltd, ceased to operate in Israel in April 2023 and is currently inactive in the country.
- Where is HeartPoint Global's headquarters located?
- HeartPoint Global's headquarters is located in Coral Gables, Florida, United States.
- How many employees does HeartPoint Global have worldwide?
- HeartPoint Global has 7 employees worldwide.